liver cancer
Conditions
Interventions
Case series:Apatinib therapy
Sponsors
Shandong Provincial Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Aged = 18 years old, male or female; 2. According with Specification for diagnosis and treatment of primary hepatocellular carcinoma(2017)Clinical diagnostic criteria or Patients with histopathology and/or cytology confirmed Primary hepatocellular carcinoma; 3. Child-pugh grade A, B patients 4. The patients are willing to join the study, and sign the informed consent; 5. Patients can benifit from apatinib at the investigator's discretion. 1. Aged = 18 years old, male or female; 2. According with Specification for diagnosis and treatment of primary hepatocellular carcinoma(2017)Clinical diagnostic criteria or Patients with histopathology and/or cytology confirmed Primary hepatocellular carcinoma; 3. Child-pugh grade A, B patients 4. The patients are willing to join the study, and sign the informed consent; 5. Patients can benifit from apatinib at the investigator's discretion.
Exclusion criteria
Exclusion criteria: 1. Child-pugh grade C patients; 2. Patients taking apatinib mesylate tablets and other similar drugs; 3. Allergic to apatinib or its excipients; 4. Pregnant and lactant women; 5. Patients with contraindications for apatinib; 6. The other situation that doctor considered not suitable for enrolling.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| OS;PFS;ORR;DCR;Safety; | — |
Countries
China
Contacts
Public ContactJun Liu
Shandong Provincial Hospital
Outcome results
None listed